Back
Salesforce Vs. Verona Pharma PLC Industry Stock Comparison
Buy
67
CRM
Salesforce
Last Price:
$344.12
Seasonality Move:
8.94%
Sell
48
VRNA
Verona Pharma PLC
Last Price:
$45.02
Seasonality Move:
1.28%
Buy
67
Salesforce (CRM)
is a Buy
Is Salesforce a Buy, Sell or Hold?
-
The current Salesforce [CRM] share price is $344.43. The Score for CRM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
CRM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Verona Pharma PLC (VRNA)
is a Sell
Is Verona Pharma PLC a Buy, Sell or Hold?
-
The current Verona Pharma PLC [VRNA] share price is $45.04. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
VRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $344.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $45.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing slight selling pressure.
CRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.17 | Buy |
Relative Strength Index (14 RSI): | 53.3 | Buy |
Chaikin Money Flow: | 1353670 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (332.12 - 356.12) | Buy |
Bollinger Bands (100): | (255.68 - 330.52) | Buy |
VRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.65 | Buy |
Relative Strength Index (14 RSI): | 68.18 | Buy |
Chaikin Money Flow: | -67723 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.54 - 42.18) | Buy |
Bollinger Bands (100): | (26.89 - 38.85) | Buy |
CRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 345.87 | Sell |
20-day SMA: | 346.85 | Sell |
50-day SMA: | 324.44 | Buy |
200-day SMA: | 281.44 | Buy |
8-day EMA: | 345.07 | Sell |
20-day EMA: | 343.39 | Buy |
50-day EMA: | 326.35 | Buy |
200-day EMA: | 285.92 | Buy |
VRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.43 | Buy |
20-day SMA: | 40.79 | Buy |
50-day SMA: | 38.03 | Buy |
200-day SMA: | 24.5 | Buy |
8-day EMA: | 42.68 | Buy |
20-day EMA: | 40.99 | Buy |
50-day EMA: | 37.9 | Buy |
200-day EMA: | 27.99 | Buy |
Salesforce Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.23 per share, an increase this year of $3.27 per share, and an increase next year of $1.84 per share.
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.
Salesforce Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Verona Pharma PLC Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |